The Immune Revolution: A Case for Priming, Not Checkpoint-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Immune Revolution: A Case for Priming, Not Checkpoint

Published:2018-04 Issue:4 Volume:33 Page:563-569
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Vonderheide Robert H.

Funder

NIH

Parker Institute for Cancer Immunotherapy

Stand Up 2 Cancer-Lustgarten Foundation

Breast Cancer Research Foundation

Penn's Basser Center for BRCA

Abramson Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference91 articles.

1. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN;Ahonen;J. Exp. Med.,2004

2. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines;Ahonen;Blood,2008

3. Metastatic progression is associated with dynamic changes in the local microenvironment;Aiello;Nat. Commun.,2016

4. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs;Albert;Nature,1998

5. Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development;Aspord;J. Exp. Med.,2007

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies in hepatopancreatobiliary cancers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Interleukin 6 and cancer resistance in glioblastoma multiforme;Neurosurgical Review;2024-09-05

3. Immune checkpoint reprogramming via sequential nucleic acid delivery strategy optimizes systemic immune responses for gastrointestinal cancer immunotherapy;Cancer Letters;2024-09

4. Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds;Journal of Controlled Release;2024-09

5. Crucial role of dendritic cells in the generation of anti-tumor T-cell responses and immunogenic tumor microenvironment to suppress tumor development;Frontiers in Immunology;2024-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3